Calvin Boon

Part of Novartis AG, Novartis Institute for Tropical Diseases Pte Ltd. is a Singaporean company that develops novel small molecule therapies for tropical infectious diseases. The company is based in Singapore, Singapore.

Established in 2008, Dx assays is Singapore's first commercial developer of molecular assays. Their company specializes in Nucleic Acid-based Test (NAT) development. They offer highly customizable services in assay design, development and validation for client-provided content in areas such as infectious disease testing, assay integration and development of companion diagnostic assays. Its laboratories are equipped with the state-of-the-art technologies and are operated by highly qualified personnel under the compliance of ISO-13485 : 2003.